RAPID MICRO BIOSYSTEMS, INC. (RPID)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 15M 30M 45M Q4 '20: 16.1M Q1 '21: 18.1M Q2 '21: 21.6M Q3 '21: 23.3M Q4 '21: 23.2M Q1 '22: 22.4M Q2 '22: 20.1M Q3 '22: 18M Q4 '22: 17.1M Q1 '23: 18M Q2 '23: 19.1M Q3 '23: 20.6M Q4 '23: 22.5M Q1 '24: 23.1M Q2 '24: 24.7M Q3 '24: 26.2M Q4 '24: 28.1M Q1 '25: 29.6M Q2 '25: 30.3M Q3 '25: 30.5M Q4 '25: 33.6M Q1 '26: 34.4M Q2 '26: 35.2M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-75M -50M -25M 0 25M 50M 75M Q4 '20: -30.5M Q1 '21: -33M Q2 '21: -37.8M Q3 '21: -42.4M Q4 '21: -47.2M Q1 '22: -52.5M Q2 '22: -55.8M Q3 '22: -60.5M Q4 '22: -63.2M Q1 '23: -63.1M Q2 '23: -64.1M Q3 '23: -61.6M Q4 '23: -56.6M Q1 '24: -56M Q2 '24: -54.3M Q3 '24: -51.9M Q4 '24: -49.9M Q1 '25: -47.3M Q2 '25: -46.1M Q3 '25: -45.4M Q4 '25: -47.4M Q1 '26: -49.6M Q2 '26: -49.8M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-75M -50M -25M 0 25M 50M 75M Q4 '20: -37.1M Q1 '21: -51.2M Q2 '21: -53.7M Q3 '21: -70.3M Q4 '21: -73.5M Q1 '22: -66.4M Q2 '22: -67.6M Q3 '22: -59M Q4 '22: -60.8M Q1 '23: -59.8M Q2 '23: -60.7M Q3 '23: -57.7M Q4 '23: -52.5M Q1 '24: -51.9M Q2 '24: -50.5M Q3 '24: -48.4M Q4 '24: -46.9M Q1 '25: -44.8M Q2 '25: -44.1M Q3 '25: -44.3M Q4 '25: -47.1M Q1 '26: -50.1M Q2 '26: -51.2M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q2 '21: -36.8M Q3 '21: -47.2M Q4 '21: -55M Q1 '22: -60.5M Q2 '22: -64M Q3 '22: -59.8M Q4 '22: -58.5M Q1 '23: -58.4M Q2 '23: -52.6M Q3 '23: -47.2M Q4 '23: -45.1M Q1 '24: -43.9M Q2 '24: -44.8M Q3 '24: -43.7M Q4 '24: -44.2M Q1 '25: -37.7M Q2 '25: -37.3M Q3 '25: -37.7M Q4 '25: -31.1M Q1 '26: -37.1M Q2 '26: -40.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q2 '21: -37.8M Q3 '21: -48.6M Q4 '21: -58.2M Q1 '22: -65.8M Q2 '22: -70.8M Q3 '22: -67.7M Q4 '22: -65.3M Q1 '23: -63.6M Q2 '23: -56M Q3 '23: -49.5M Q4 '23: -46.9M Q1 '24: -45.6M Q2 '24: -46.8M Q3 '24: -45.4M Q4 '24: -45.5M Q1 '25: -38.8M Q2 '25: -38.3M Q3 '25: -38.6M Q4 '25: -31.9M Q1 '26: -38M Q2 '26: -40.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '20: 353.5K Q3 '20: 356.1K Q1 '21: 641.4K Q2 '21: 694.7K Q3 '21: 35.3M Q1 '22: 42.2M Q2 '22: 42.5M Q3 '22: 42.5M Q1 '23: 42.8M Q2 '23: 43.1M Q3 '23: 43.1M Q1 '24: 43.2M Q2 '24: 43.6M Q3 '24: 43.7M Q1 '25: 44M Q2 '25: 44.6M Q3 '25: 45M Q1 '26: 45.4M Q2 '26: 48.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-150.00 -100.00 -50.00 0.00 50.00 100.00 150.00 Q4 '20: -126.11 Q1 '21: -136.81 Q2 '21: -124.89 Q3 '21: -95.52 Q4 '21: -3.94 Q1 '22: 33.60 Q2 '22: 53.30 Q3 '22: 53.63 Q4 '22: -1.42 Q1 '23: -1.39 Q2 '23: -1.41 Q3 '23: -1.34 Q4 '23: -1.22 Q1 '24: -1.21 Q2 '24: -1.17 Q3 '24: -1.12 Q4 '24: -1.08 Q1 '25: -1.03 Q2 '25: -1.01 Q3 '25: -1.01 Q4 '25: -1.06 Q1 '26: -1.11 Q2 '26: -1.11 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.